by Scott Larrivee | Feb 7, 2025 | News
WEST VALLEY CITY, Utah – Feb. 7, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CFO Pushkar Bedekar will present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11,...
by Scott Larrivee | Jan 22, 2025 | Podcast
On our first episode of ‘Talk Radioisotopes: Going Nuclear on Cancer,’ host Scott Larrivee is joined by co-host Dr. Sarah Scouten and guest Jeff Jones of Oppenheimer & Company.The discussion covers the latest trends in the radiopharmaceutical and...
by Scott Larrivee | Oct 7, 2024 | News
VALENCIA, Calif. – Oct. 7, 2024 – Nusano, Inc., a physics company transforming the production of radioisotopes, today announced it will speak at three industry conferences in October 2024. Oppenheimer 2nd Annual Targeted Radiopharmaceutical Therapies in...
by Scott Larrivee | Sep 28, 2023 | News
NEW YORK – September 28, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced that senior management will participate in the following investor conferences in October. William Blair Virtual Radiopharma Conference...